Patent · US Expired

2-oxy-4H-3,1-benzoxazin-4-ones and related compounds and pharmaceutical use

US4745116A · kind A · utility

13Cited by
1References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 1986
Grant dateMay 17, 1988
Priority date
Expiry dateDec 23, 2006

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65335
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

2-Oxy-4H-3,1-benzoxazin-4-ones, useful as serine protease inhibitors, represented by the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: PA0 a is an integer of 1 to 4; PA0 A is a bond, or alkylene having one to eight carbon atoms; PA0 R is hydrogen, phenyl, imidazolyl or cycloalkyl having three to six carbon atoms, wherein the phenyl, imidazolyl or cycloalkyl ring is optionally substituted with 1 to 3 substituents independently selected from the group consisting of lower alkyl having one to four carbon atoms, lower alkoxy having one to four carbon atoms, --N(R.sup.1).sub.2, --NO.sub.2, halo or lower alkylthio having one to four carbon atoms, and, PA0 each R' is independently selected from the group consisting of hydroxy, benzyloxy, lower alkyl having one to six atoms, lower alkenyl having two to six carbon atoms, lower alkoxy having one to six carbon atoms, lower alkylthio or halo-lower alkyl having one to six carbon atoms, halo, --NO.sub.2, --N(R.sup.1).sub.2, --NR.sup.1 CO.sub.2 R.sup.2, --NR.sup.1 COR.sup.2, and --NR.sup.1 C(O)N(R.sup.1).sub.2, PA0 in which PA1 each R.sup.1 is independently hydrogen or lower alkyl having one to four ca…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.